• Most Popular
  • Most Shared

Labopharm gets Health Canada nod for tramadol

Mon Jun 18, 2007 7:13am EDT

Stocks

   

TORONTO, June 18 (Reuters) - Labopharm Inc. (DDS.TO) said on Monday it expects to begin selling its once-daily pain formula, tramadol, in Canada later this year after it received a Notice of Compliance from Health Canada.

The company said it is in talks to complete a licensing and distribution agreement for the drug, which will see the company retain the right to co-promote the product to certain specialties through its own sales force.

($1=$1.07 Canadian)



More from Reuters

A Greenpeace activist dressed as one of the "Four Horsemen of the Apocalypse" rides outside the parliament building during a brief protest in Copenhagen December 13, 2009. REUTERS/Christian Charisius

The face of climate protest

Protesters around the globe called for an end to global warming as climate talks in Copenhagen entered their sixth day.  Video 

    Climate conference
    In this photo reviewed by the U.S. Military, a guard leans on a fencepost as a Guantanamo detainee (L) jogs inside the exercise yard at Camp 5 detention center, at the U.S. Naval Base in Guantanamo Bay, January 21, 2009. REUTERS/Brennan Linsley/Pool

    Life after Guantanamo

    Critics are worried that Gitmo prisoners once dubbed "enemy combatants" will be using prisons as pulpits for anti-American rhetoric once they're moved to U.S. soil.  Full Article 

    U.S.
    Lockheed Martin Chief Executive Robert Stevens answers a question during the Reuters Aerospace and Defense Summit in Washington December 14, 2009. REUTERS/Molly Riley

    Lockheed eyes deals

    The future demands of cybersecurity make that sector one of many the aerospace giant sees as an acquisition target in the coming year.  Full Article 

    Aerospace and Defense Summit